Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.21 Million USD | 32.6% |
| 2022 | 4.68 Million USD | 468.94% |
| 2021 | 824.31 Thousand USD | 290.64% |
| 2020 | 211.01 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 7.85 Million USD | 63.29% |
| 2024 Q1 | 4.81 Million USD | -22.6% |
| 2023 FY | 6.21 Million USD | 32.6% |
| 2023 Q2 | 9.33 Million USD | 82.67% |
| 2023 Q1 | 5.11 Million USD | 9.02% |
| 2023 Q4 | 6.21 Million USD | -23.38% |
| 2023 Q3 | 8.11 Million USD | -13.1% |
| 2022 Q2 | 1.1 Million USD | 3.75% |
| 2022 Q1 | 1.06 Million USD | 28.75% |
| 2022 FY | 4.68 Million USD | 468.94% |
| 2022 Q4 | 4.68 Million USD | -26.92% |
| 2022 Q3 | 6.41 Million USD | 482.85% |
| 2021 Q2 | 533.12 Thousand USD | 0.0% |
| 2021 FY | 824.31 Thousand USD | 290.64% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 824.31 Thousand USD | 18.36% |
| 2021 Q3 | 696.46 Thousand USD | 30.64% |
| 2020 Q4 | 211.01 Thousand USD | 0.0% |
| 2020 FY | 211.01 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 96.552% |
| AngioDynamics, Inc. | 317.67 Million USD | 98.042% |
| AtriCure, Inc. | 613.93 Million USD | 98.987% |
| Avinger, Inc. | 13.77 Million USD | 54.838% |
| Azenta, Inc. | 2.88 Billion USD | 99.784% |
| BioLife Solutions, Inc. | 412.71 Million USD | 98.493% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.947% |
| Daxor Corporation | 34.86 Million USD | 82.165% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | 78.495% |
| Femasys Inc. | 27.75 Million USD | 77.595% |
| GlucoTrack, Inc. | 4.9 Million USD | -26.784% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 95.473% |
| Hologic, Inc. | 9.15 Billion USD | 99.932% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.858% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.96% |
| KORU Medical Systems, Inc. | 28.46 Million USD | 78.15% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 98.207% |
| Innovative Eyewear, Inc. | 6.21 Million USD | 0.0% |
| Masimo Corporation | 3.04 Billion USD | 99.796% |
| Microbot Medical Inc. | 8.32 Million USD | 25.318% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 96.383% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 99.733% |
| Nephros, Inc. | 11.86 Million USD | 47.57% |
| NovoCure Limited | 1.14 Billion USD | 99.457% |
| NEXGEL, Inc. | 9.95 Million USD | 37.531% |
| NEXGEL, Inc. | 9.95 Million USD | 37.531% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 97.657% |
| OraSure Technologies, Inc. | 482.84 Million USD | 98.712% |
| Pro-Dex, Inc. | 54.21 Million USD | 88.528% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 89.772% |
| Predictive Oncology Inc. | 14.41 Million USD | 56.866% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | 63.23% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.927% |
| Repligen Corporation | 2.82 Billion USD | 99.78% |
| Sanara MedTech Inc. | 73.87 Million USD | 91.582% |
| STAAR Surgical Company | 488.69 Million USD | 98.727% |
| Sharps Technology, Inc. | 11.78 Million USD | 47.251% |
| Utah Medical Products, Inc. | 135.45 Million USD | 95.409% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.916% |
| Jin Medical International Ltd. | 32.9 Million USD | 81.1% |